(Q34327991)

English

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

circulatory system

1 reference

based on heuristic

inferred from title

Alberto Zanchetti

object named as

Alberto Zanchetti

14

0 references

Sverre E. Kjeldsen

2

object named as

Sverre E Kjeldsen

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

author name string

Stevo Julius

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Michael Weber

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hans R Brunner

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Steffan Ekman

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lennart Hansson

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Tsushung Hua

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

John Laragh

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Gordon T McInnes

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Lada Mitchell

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Francis Plat

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Anthony Schork

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Beverly Smith

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

VALUE trial group

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

language of work or name

0 references

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

363

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

9426

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

2022-2031

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Shanghai trial of nifedipine in the elderly (STONE)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Principal Results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood pressure, stroke, and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose-response efficacy of valsartan, a new angiotensin II receptor blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of isolated systolic hypertension: the SHELL study results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2804%2916451-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(04)16451-9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34327991&oldid=1547260563"